May 15th 2025
Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Small-Molecule Drug Development: Recent Study Suggests Limited Binding Sites
June 2nd 2013A recent study of computer-created and natural proteins suggests the number of sites where small-molecule drugs can bind to proteins is limited, thereby narrowing how to mitigate side effects through drug design.